Zurcher Kantonalbank (Zurich Cantonalbank) - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 244 filers reported holding HAEMONETICS CORP in Q2 2022. The put-call ratio across all filers is 1.27 and the average weighting 0.1%.

Quarter-by-quarter ownership
Zurcher Kantonalbank (Zurich Cantonalbank) ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$1,204,493
+66.7%
13,446
+58.4%
0.01%
+66.7%
Q2 2023$722,583
+8.9%
8,487
+5.8%
0.00%0.0%
Q1 2023$663,821
+20.8%
8,022
+14.8%
0.00%0.0%
Q4 2022$549,606
+14.3%
6,988
+7.5%
0.00%0.0%
Q3 2022$481,000
+13.4%
6,5030.0%0.00%
+50.0%
Q2 2022$424,000
-4.9%
6,503
-7.8%
0.00%0.0%
Q1 2022$446,000
+19.3%
7,0510.0%0.00%0.0%
Q4 2021$374,000
+3.9%
7,051
+38.1%
0.00%0.0%
Q3 2021$360,000
+25.0%
5,106
+18.3%
0.00%0.0%
Q2 2021$288,000
-47.3%
4,316
-12.3%
0.00%
-33.3%
Q1 2021$546,000
-27.8%
4,921
-22.7%
0.00%
-40.0%
Q4 2020$756,000
+53.7%
6,364
+12.8%
0.01%
+66.7%
Q3 2020$492,000
-2.6%
5,6430.0%0.00%
-25.0%
Q2 2020$505,000
+22.3%
5,643
+36.0%
0.00%0.0%
Q1 2020$413,000
+2.5%
4,148
+18.3%
0.00%
+33.3%
Q4 2019$403,000
-8.8%
3,5050.0%0.00%
-25.0%
Q3 2019$442,000
+9.7%
3,505
+4.8%
0.00%
+33.3%
Q2 2019$403,000
+37.5%
3,3460.0%0.00%0.0%
Q1 2019$293,000
-60.8%
3,346
-55.2%
0.00%
-62.5%
Q4 2018$747,000
-12.6%
7,4620.0%0.01%
+14.3%
Q3 2018$855,000
-11.6%
7,462
-30.8%
0.01%
-22.2%
Q2 2018$967,000
+8.9%
10,783
-11.1%
0.01%
+12.5%
Q1 2018$888,000
+26.0%
12,1320.0%0.01%
+33.3%
Q4 2017$705,000
+81.7%
12,132
+40.3%
0.01%
+50.0%
Q3 2017$388,000
+506.2%
8,649
+430.0%
0.00%
+300.0%
Q2 2017$64,000
+12.3%
1,632
+16.8%
0.00%0.0%
Q1 2017$57,000
+1.8%
1,3970.0%0.00%0.0%
Q4 2016$56,000
+9.8%
1,3970.0%0.00%0.0%
Q3 2016$51,000
+50.0%
1,397
+19.0%
0.00%
Q2 2016$34,000
-17.1%
1,1740.0%0.00%
-100.0%
Q1 2016$41,000
+7.9%
1,1740.0%0.00%
Q4 2015$38,000
+123.5%
1,174
+129.3%
0.00%
Q3 2015$17,000
+54.5%
512
+95.4%
0.00%
Q2 2015$11,000
-8.3%
2620.0%0.00%
Q1 2015$12,000
-98.8%
262
-99.1%
0.00%
-100.0%
Q1 2014$978,000
-88.3%
30,000
-85.7%
0.03%
-89.7%
Q3 2013$8,389,000
+6.0%
210,360
+9.9%
0.29%
+4.7%
Q2 2013$7,917,000
+12.1%
191,460
+13.0%
0.28%
+11.7%
Q1 2013$7,060,000
+25.4%
169,460
+22.9%
0.25%
+12.2%
Q4 2012$5,629,000137,8300.22%
Other shareholders
HAEMONETICS CORP shareholders Q2 2022
NameSharesValueWeighting ↓
LGT CAPITAL PARTNERS LTD. 1,216,059$64,500,0001.72%
HEARTLAND ADVISORS INC 406,192$21,544,0001.26%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$10,608,0001.22%
Aurora Investment Counsel 32,149$1,705,0001.01%
Endurant Capital Management LP 73,914$3,920,0000.95%
KINGDON CAPITAL MANAGEMENT, L.L.C. 135,000$7,160,0000.82%
ARMISTICE CAPITAL, LLC 872,000$46,251,0000.76%
Summit Creek Advisors LLC 131,357$6,967,0000.70%
Dean Capital Management 15,309$812,0000.70%
Keene & Associates, Inc. 11,720$622,0000.54%
View complete list of HAEMONETICS CORP shareholders